Literature DB >> 15865093

Clinical impact of metastatic lymph node ratio in advanced gastric cancer.

Chikara Kunisaki1, Hiroshi Shimada, Masato Nomura, Goro Matsuda, Yuichi Otsuka, Hidetaka Ono, Hirotoshi Akiyama.   

Abstract

BACKGROUND: We examined the prognostic value of metastatic lymph node ratio (the ratio of the number of metastatic lymph nodes to the number of lymph nodes removed) after curative resection. PATIENTS AND METHODS: The results of surgery on 758 patients were assessed by uni-and multi-variate analysis by classifying the metastatic lymph node ratio into 4 categories: 0, <0.1, >0.1 <0.2, >0.2. Furthermore, the rationality and prognostic significance of the lymph node ratio classification as a nodal staging system was compared with the UICC/TNM classification.
RESULTS: Univariate analysis showed that operative method, location of tumor, macroscopic appearance, tumor diameter, depth of invasion, metastatic lymph node ratio, lymphatic invasion and venous invasion significantly affected prognosis. A Cox proportional regression hazard model revealed that macroscopic appearance, tumor diameter, depth of invasion and metastatic lymph node ratio independently influenced prognosis. Among patients with pN2 by the UICC/TNM classification, survival in those with a metastatic lymph node ratio less than 0.1 was significantly better than in those with a higher metastatic lymph node ratio.
CONCLUSIONS: The metastatic lymph node ratio is an independent prognostic factor. Extended lymphadenectomy could increase survival of patients with pN2 gastric cancer by decreasing the metastatic lymph node ratio below 0.1.

Entities:  

Mesh:

Year:  2005        PMID: 15865093

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  22 in total

1.  Large metastatic lymph node size, especially more than 2 cm: independent predictor of poor prognosis in node-positive gastric carcinoma.

Authors:  O Cheong; S T Oh; B S Kim; J H Yook; J H Kim; J T Im; G C Park
Journal:  World J Surg       Date:  2008-02       Impact factor: 3.352

2.  How does epidemiological and clinicopathological features affect survival after gastrectomy for gastric cancer patients-single Egyptian center experience.

Authors:  Ehab El Hanafy; Ayman El Nakeeb; Helmy Ezzat; Emad Hamdy; Ehab Atif; Tharwat Kandil; Amgad Fouad; Mohamed Abdel Wahab; Ahmed Monier
Journal:  World J Gastrointest Surg       Date:  2016-06-27

3.  Positive Lymph Node Ratio as an Indicator of Prognosis and Local Tumor Clearance in N3 Gastric Cancer.

Authors:  Shuhei Komatsu; Daisuke Ichikawa; Mahito Miyamae; Toshiyuki Kosuga; Kazuma Okamoto; Tomohiro Arita; Hirotaka Konishi; Ryo Morimura; Yasutoshi Murayama; Atsushi Shiozaki; Yoshiaki Kuriu; Hisashi Ikoma; Masayoshi Nakanishi; Hitoshi Fujiwara; Eigo Otsuji
Journal:  J Gastrointest Surg       Date:  2016-06-28       Impact factor: 3.452

4.  Metastatic lymph node ratio: a new staging system for gastric cancer.

Authors:  Roberto Persiani; Stefano Rausei; Vincenzo Antonacci; Alberto Biondi; Francesco Casella; Luigi Ciccoritti; Domenico D'Ugo
Journal:  World J Surg       Date:  2009-10       Impact factor: 3.352

5.  Determining of metastatic lymph node ratio in patients who underwent D2 dissection for gastric cancer.

Authors:  Ahmet Bilici; Mesut Seker; Bala Basak Oven Ustaalioglu; Burcak Yilmaz; Alper Doventas; Taflan Salepci; Mahmut Gumus
Journal:  Med Oncol       Date:  2009-11-03       Impact factor: 3.064

6.  Superiority of log odds of positive lymph nodes (LODDS) for prognostic prediction after gastric cancer surgery: a multi-institutional analysis of 7620 patients in China.

Authors:  Pengfei Gu; Jingyu Deng; Zhe Sun; Zhenning Wang; Wei Wang; Han Liang; Huimian Xu; Zhiwei Zhou
Journal:  Surg Today       Date:  2020-08-04       Impact factor: 2.549

7.  Robotic gastrectomy versus laparoscopic gastrectomy for gastric cancer: comparison of surgical performance and short-term outcomes.

Authors:  Zhou Junfeng; Shi Yan; Tang Bo; Hao Yingxue; Zeng Dongzhu; Zhao Yongliang; Qian Feng; Yu Peiwu
Journal:  Surg Endosc       Date:  2014-01-03       Impact factor: 4.584

8.  The Lymph Node Ratio Is an Independent Prognostic Factor in Esophageal Cancer Patients Who Receive Curative Surgery.

Authors:  Norio Yukawa; Toru Aoyama; Hiroshi Tamagawa; Ayako Tamagawa; Yosuke Atsumi; Shinnosuke Kawahara; Yukio Maezawa; Kazuki Kano; Masaaki Murakawa; Keisuke Kazama; Masakatsu Numata; Takashi Oshima; Munetaka Masuda; Yasushi Rino
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

9.  Comparison of four staging systems of lymph node metastasis in gastric cancer.

Authors:  Ming Zhang; Guanyu Zhu; Yan Ma; Yingwei Xue
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

10.  Clinical significance of the metastatic lymph-node ratio in early gastric cancer.

Authors:  Chikara Kunisaki; Hirochika Makino; Hirotoshi Akiyama; Yuichi Otsuka; Hidetaka A Ono; Takashi Kosaka; Ryo Takagawa; Yutaka Nagahori; Masazumi Takahashi; Fumihiko Kito; Hiroshi Shimada
Journal:  J Gastrointest Surg       Date:  2007-09-13       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.